NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
REDAlemtuzumab Lemtrada® Malignant disease and immunosuppression, Anti-lymphocyte monoclonal antibodies, 08.02.03
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Alemtuzumab Alemtuzumab Immune System, Immune System Disorders And Transplantation, Multiple Sclerosis, Immunosuppressants Monoclonal Antibodies
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.
Links found
MHRA Drug Safety Update: Lemtrada¥ (alemtuzumab): updated restrictions and strengthened monitoring requirements following review of serious cardiovascular and immune-mediated reactions (February 2020)
NICE TA312: Alemtuzumab for treating relapsing‑remitting multiple sclerosis
NICE TA312: Alemtuzumab for treating relapsing‑remitting multiple sclerosis
SCG: Alemtuzumab for treating relapsing-remitting multiple sclerosis